160 related articles for article (PubMed ID: 17615737)
1. [MMW drug award for gemcitabine. Cytostatic drug with growing indications].
Füessl HS
MMW Fortschr Med; 2006 Nov; 148(45):6-7. PubMed ID: 17615737
[No Abstract] [Full Text] [Related]
2. Gemcitabine for pancreatic cancer: how hard to look for clinical benefit? An American perspective.
Gelber RD
Ann Oncol; 1996 Apr; 7(4):335-7. PubMed ID: 8805922
[No Abstract] [Full Text] [Related]
3. ODAC recommends full approval for Gemzar for pancreatic cancer.
Oncology (Williston Park); 1995 Sep; 9(9):799-800. PubMed ID: 8562322
[No Abstract] [Full Text] [Related]
4. Docetaxel and gemcitabine released for cancer chemotherapy.
Am J Health Syst Pharm; 1996 Jul; 53(14):1643, 1649. PubMed ID: 8827226
[No Abstract] [Full Text] [Related]
5. Chemotherapy: Gemcitabine remains the standard of care for pancreatic cancer.
Berlin J; Benson AB
Nat Rev Clin Oncol; 2010 Mar; 7(3):135-7. PubMed ID: 20190797
[No Abstract] [Full Text] [Related]
6. Gemcitabine: a ray of hope for pancreatic cancer?
Gupta P
Natl Med J India; 1997; 10(2):72-3. PubMed ID: 9153984
[No Abstract] [Full Text] [Related]
7. Will gemcitabine monotherapy be dethroned as the adjuvant chemotherapy in pancreatic adenocarcinoma?
Kourie HR; Gharios J; Kattan J
Future Oncol; 2017 Feb; 13(3):197-199. PubMed ID: 27624286
[No Abstract] [Full Text] [Related]
8. Options for the treatment of gemcitabine-resistant advanced pancreatic cancer: are we there yet?
Saif MW
JOP; 2010 May; 11(3):288-9; author reply 290. PubMed ID: 20442533
[No Abstract] [Full Text] [Related]
9. Personal experience in advanced pancreatic cancer: retrospective analysis on the use of 5-fluorouracil or gemcitabine.
Martinelli B; Pigni A; Fagnoni E; Chini C; Vallini I; Pinotti G
Dig Liver Dis; 2001; 33(6):503. PubMed ID: 11572580
[No Abstract] [Full Text] [Related]
10. FDA expands access to gemcitabine for pancreatic cancer.
Am J Health Syst Pharm; 1995 May; 52(9):931. PubMed ID: 7641030
[No Abstract] [Full Text] [Related]
11. Gemcitabine doublets in advanced pancreatic cancer: should we move on?
Rocha Lima CM; Flores AM
J Clin Oncol; 2006 Jan; 24(3):327-9. PubMed ID: 16344312
[No Abstract] [Full Text] [Related]
12. [Gemcitabine treatment of pancreatic cancer peritonitis].
Horiki N; Maruyama M; Fujita Y; Suzuki Y; Tanaka T; Shimomura M; Tanigawa K; Sasaki H; Fujiwara M; Suzuki K; Imoto I; Adachi Y
Nihon Shokakibyo Gakkai Zasshi; 2003 Jan; 100(1):73-8. PubMed ID: 12601933
[No Abstract] [Full Text] [Related]
13. Gemcitabine--a major advance?
Thomas A; Steward WP
Ann Oncol; 1998 Dec; 9(12):1265-7. PubMed ID: 9932153
[No Abstract] [Full Text] [Related]
14. [Gemzar (gemcitabine)--a new chemotherapeutic agent for pancreatic cancer].
Merimsky O; Chaitchik S
Harefuah; 1997 Sep; 133(5-6):208-12. PubMed ID: 9461693
[No Abstract] [Full Text] [Related]
15. Clinical benefit as a primary efficacy endpoint.
Ballatori E; Del Favero A; Roila F
J Clin Oncol; 1998 Feb; 16(2):803-4. PubMed ID: 9469377
[No Abstract] [Full Text] [Related]
16. Adjuvant chemotherapy with gemcitabine for patients with resectable pancreatic cancer.
Shivnani AT
JAMA; 2007 Jun; 297(23):2581-2; author reply 2582. PubMed ID: 17579222
[No Abstract] [Full Text] [Related]
17. Correlation of basal EGFR expression with pancreatic cancer grading but not with clinical outcome after gemcitabine-based treatment.
Funel N; Vasile E; Del Chiaro M; Boggi U; Falcone A; Campani D; Scarpa A; Giovannetti E
Ann Oncol; 2011 Feb; 22(2):482-4. PubMed ID: 21196439
[No Abstract] [Full Text] [Related]
18. Trial of adjuvant gemcitabine for pancreatic cancer: the jury is still out.
Palmer DH
Pancreatology; 2007; 7(5-6):548; author reply 549. PubMed ID: 17901720
[No Abstract] [Full Text] [Related]
19. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of gemcitabine for the treatment of pancreatic cancer.
Ward S; Morris E; Bansback N; Calvert N; Crellin A; Forman D; Larvin M; Radstone D
Health Technol Assess; 2001; 5(24):1-70. PubMed ID: 11701098
[No Abstract] [Full Text] [Related]
20. Phase I trial dosing of gemcitabine and concurrent involved field irradiation in patients with localized pancreatic carcinomas.
Nanfro JJ
J Clin Oncol; 1999 Nov; 17(11):3692. PubMed ID: 10550172
[No Abstract] [Full Text] [Related]
[Next] [New Search]
